Product Details

Med-Rivastigmine

Rivastigmine
4.5 mg
Capsule


DIN/PIN/NPN

02401630

Manufacturer

Generic Medical Partners Inc.

Formulary Listing Date

2014-01-30  

Unit Price

0.6514

Amount MOH Pays

0.6514

Coverage Status

Limited Use Product

ODB Formulary Therapeutic Classification

Therapeutic Note

NO

ATC Code

N06DA03

Interchangeable Products

DIN/ PIN/ NPN Brand name Unit Price Amount MOH pays
02324598 Sandoz Rivastigmine 0.6514 0.6514
02306050 PMS-Rivastigmine 0.6515 0.6514
02407000 Mint-Rivastigmine 0.6515 0.6514
02401630 Med-Rivastigmine 0.6514 0.6514
02485389 Jamp Rivastigmine 0.6514 0.6514
02242117 Exelon 3.1810 0.6514
02336731 Apo-Rivastigmine 0.6515 0.6514
 

LU Clinical Criteria

LU Code Auth. Period Clinical Criteria
347 1 year

Initial Trial: For patients with mild to moderate Alzheimer's Disease (Mini-Mental State Exam [MMSE] 10-26). Patients will be reimbursed for a period of up to 3 months after which continued treatment must be reassessed.

Network note: Maximum duration 3 months.

348 1 year

Continuation: Further reimbursement will be made available to those patients whose disease has not progressed/deteriorated while on this drug. Patients must continue to have a MMSE score of 10-26.

 

EAP Criteria

NO

Product Monograph

View Monograph